1. The European Agency for the Evaluation of Medicinal Products, London, CPMP note for guidance on investigation of bioavailability and bioequivalence, 1992.
2. Assessing equivalence of inhaled products;Snell;J. Pharm. Pharmacol.,1997
3. Sample sizes for comparative inhaled corticosteroid trials with emphasis on showing therapeutic equivalence;Zanen;Eur. J. Clin. Pharmacol.,1995
4. The European Agency for the Evaluation of Medicinal Products, London, CPMP Note for guidance on replacement of chlorofluorocarbons (CFC's) in metered dose inhalation products, 1993.
5. The European Agency for the Evaluation of Medicinal Products, London, CPMP note for guidance on clinical requirements for locally-applied, locally-acting products containing known constituents, 1995.